34 results on '"Graham, Mindy K."'
Search Results
2. Telomere alterations in neurofibromatosis type 1-associated solid tumors
3. The TERT promoter is polycomb-repressed in neuroblastoma cells with long telomeres
4. Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer
5. DAXX promotes centromeric stability independently of ATRX by preventing the accumulation of R-loop-induced DNA double-stranded breaks.
6. Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer
7. Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors
8. Supplementary Tables 1-4 from Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells
9. Data from Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells
10. Supplementary Figures 1-6 from Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells
11. Supplementary Materials and Methods from Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells
12. Cover Image: Volume 83 Issue 3
13. Single‐cell atlas of epithelial and stromal cell heterogeneity by lobe and strain in the mouse prostate
14. Publisher Correction: Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors
15. MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancer
16. Single-cell atlas of epithelial and stromal cell heterogeneity by lobe and strain in the mouse prostate
17. Inhibition of transcription by platinated triplex-forming oligonucleotides
18. Abstract 157: Pervasive promoter hypermethylation of silenced TERT alleles in human cancers
19. Telomere lengths differ significantly between small-cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate
20. Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells
21. Abstract B14: Establishment and characterization of in vitro models of alternative lengthening of telomeres (ALT) in pediatric high-grade glioma
22. Alternative lengthening of telomeres and ATRX/DAXX loss can reliably be detected in fine needle aspirates of pancreatic neuroendocrine tumors
23. Genetic alterations associated with ALTered telomeres
24. ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner
25. MYC drives overexpression of telomerase RNA ( hTR / TERC ) in prostate cancer
26. Abstract 3412: Functional knockout ofATRXorDAXXpermits the alternative lengthening of telomeres (ALT) mechanism in prostate cancer cells
27. Abstract 3464: CRISPR-mediated inactivation of ATRX and DAXX in pancreatic neuroendocrine tumor cell lines
28. Comprehensive assessment of ATRX mutation, protein expression, and alternative lengthening of telomeres (ALT) phenotype in grade II and III gliomas.
29. Alternative lengthening of telomeres and ATRX/DAXX loss can be reliably detected in FNAs of pancreatic neuroendocrine tumors
30. Abstract 4767: Generating and characterizing novel prostate cancer cell lines that employ the alternative lengthening of telomeres (ALT) telomere maintenance mechanism
31. MYC drives overexpression of telomerase RNA ( hTR/ TERC) in prostate cancer.
32. Targeting the Human Androgen Receptor Gene with Platinated Triplex-Forming Oligonucleotides
33. Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer.
34. Single-cell atlas of epithelial and stromal cell heterogeneity by lobe and strain in the mouse prostate.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.